Yanzhao Zhou

818 total citations
36 papers, 600 citations indexed

About

Yanzhao Zhou is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Yanzhao Zhou has authored 36 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Immunology. Recurrent topics in Yanzhao Zhou's work include Receptor Mechanisms and Signaling (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Renin-Angiotensin System Studies (5 papers). Yanzhao Zhou is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Renin-Angiotensin System Studies (5 papers). Yanzhao Zhou collaborates with scholars based in China, Israel and United Kingdom. Yanzhao Zhou's co-authors include Zhihua Qiu, Yuhua Liao, Zihua Zhou, Shijun Yang, Xiao Chen, Hongrong Zhang, Yajie Pan, Fen Chen, Dan Ding and Jibin Lin and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of the American College of Cardiology.

In The Last Decade

Yanzhao Zhou

31 papers receiving 586 citations

Peers

Yanzhao Zhou
Yanzhao Zhou
Citations per year, relative to Yanzhao Zhou Yanzhao Zhou (= 1×) peers Tetsuo Fujimaki

Countries citing papers authored by Yanzhao Zhou

Since Specialization
Citations

This map shows the geographic impact of Yanzhao Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanzhao Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanzhao Zhou more than expected).

Fields of papers citing papers by Yanzhao Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanzhao Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanzhao Zhou. The network helps show where Yanzhao Zhou may publish in the future.

Co-authorship network of co-authors of Yanzhao Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yanzhao Zhou. A scholar is included among the top collaborators of Yanzhao Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanzhao Zhou. Yanzhao Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yiran, et al.. (2025). DiffusionLoc: A diffusion model-based framework for crowd localization. Image and Vision Computing. 155. 105439–105439.
2.
Hu, Penghui, Hui Xiong, Yan Cui, et al.. (2025). Macrophage-specific PHGDH protects against MAFLD by suppressing TAK1. Cell Reports. 44(3). 115426–115426. 1 indexed citations
3.
Hu, Penghui, Hui Xiong, Jinrong Wang, et al.. (2025). Phosphoglycerate dehydrogenase interacts with and inhibits the protein kinase TAK1 to mitigate septic shock. Journal of Biological Chemistry. 301(10). 110658–110658.
4.
Wang, Baochen, Yanan Zhang, Yanzhao Zhou, et al.. (2024). Riboflavin kinase binds and activates inducible nitric oxide synthase to reprogram macrophage polarization. Redox Biology. 78. 103413–103413. 6 indexed citations
5.
Li, Zihan, et al.. (2024). Induction of MTHFD2 in Macrophages Inhibits Reactive Oxygen Species–mediated NF-κB Activation and Protects against Inflammatory Responses. The Journal of Immunology. 212(8). 1345–1356. 2 indexed citations
6.
Zhou, Yanzhao, Xin Li, Wu Zhi, et al.. (2024). The novel vaccines targeting interleukin-1 receptor type I. International Immunopharmacology. 132. 111941–111941. 4 indexed citations
7.
Yang, Shijun, Yanzhao Zhou, Yumiao Wei, et al.. (2022). Safety Assessment of Microcatheter-Protected Rotational Atherectomy with the Double Guiding Catheter Technique for Severely Calcified Left Main Bifurcation. Journal of Interventional Cardiology. 2022. 1–8.
8.
Zhou, Yanzhao, Xiang Cheng, Tong Zhao, et al.. (2022). Preliminary Intermittent Hypoxia Training Alleviates the Damage of Sustained Normobaric Hypoxia on Human Hematological Indexes and Cerebral White Matter. High Altitude Medicine & Biology. 23(3). 273–283. 6 indexed citations
9.
Zhou, Yanzhao, Feng Yan, Xue Han, et al.. (2022). NB-3 expression in endothelial cells contributes to the maintenance of blood brain barrier integrity in a mouse high-altitude cerebral edema model. Experimental Neurology. 354. 114116–114116. 4 indexed citations
10.
Ma, Wenrui, Zhihua Qiu, Xiao Chen, et al.. (2021). Inhibition of microRNA-30a alleviates vascular remodeling in pulmonary arterial hypertension. Molecular Therapy — Nucleic Acids. 26. 678–693. 12 indexed citations
11.
Zhou, Yanzhao, Meng Qiao, Xin Huang, et al.. (2021). Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain. Alzheimer s Research & Therapy. 13(1). 194–194. 18 indexed citations
12.
Wang, Yingxuan, Chanjuan Xu, Yanzhao Zhou, et al.. (2021). Anti-ATR001 monoclonal antibody ameliorates atherosclerosis through beta-arrestin2 pathway. Biochemical and Biophysical Research Communications. 544. 1–7. 6 indexed citations
13.
Zhang, Kai, Yajie Pan, Yanzhao Zhou, et al.. (2019). Vaccine Targeted Alpha 1D-Adrenergic Receptor for Hypertension. Hypertension. 74(6). 1551–1562. 17 indexed citations
14.
Zhao, Ming, Xiang Cheng, Ying Han, et al.. (2019). Metformin administration prevents memory impairment induced by hypobaric hypoxia in rats. Behavioural Brain Research. 363. 30–37. 16 indexed citations
15.
Deng, Yihuan, Xiao Chen, Yanzhao Zhou, et al.. (2017). Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine. Scientific Reports. 7(1). 12580–12580. 23 indexed citations
16.
Pan, Yajie, Yanzhao Zhou, Xiao Chen, et al.. (2017). A Therapeutic Peptide Vaccine Against PCSK9. Scientific Reports. 7(1). 12534–12534. 74 indexed citations
17.
Zhou, Yanzhao, Shijia Wang, Zhihua Qiu, et al.. (2016). ATRQβ-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice. Journal of Hypertension. 34(3). 474–485. 17 indexed citations
18.
Zhang, Kuan, Yanzhao Zhou, Tong Zhao, et al.. (2015). Reduced Cerebral Oxygen Content in the DG and SVZ In Situ Promotes Neurogenesis in the Adult Rat Brain In Vivo. PLoS ONE. 10(10). e0140035–e0140035. 25 indexed citations
19.
Yang, Shijun, Qi Zhong, Zhihua Qiu, et al.. (2014). Angiotensin II receptor type 1 autoantibodies promote endothelial microparticles formation through activating p38 MAPK pathway. Journal of Hypertension. 32(4). 762–770. 20 indexed citations
20.
Qiu, Zhihua, Xiao Chen, Yanzhao Zhou, et al.. (2013). Therapeutic Vaccines against Human and Rat Renin in Spontaneously Hypertensive Rats. PLoS ONE. 8(6). e66420–e66420. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026